CHCWM – Cancer & Hematology Centers of West Michigan

In the News

As the largest physician-owned oncology and hematology practice in Michigan, we are often in the news. See what we've been up to.
Yuanbin Chen, MD, JTO Clinical & Research Reports

Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, is published from CASPIAN on JTO as first author from CHCWM. DR. Chen reports this is the first time that immunotherapy plus chemotherapy works in small cell lung cancer Read more »


Yuanbin Chen, MD, European Lung Cancer Congress

Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, is featured in a study with the European Lung Cancer Congress, Characteristics of Long-Term Survivors in the CASPIAN study. “There were >3 times as many LTS in the D+EP Read more »


APP Nurse Practitioner Tami Groothuis
CHCWM’s Tami Groothuis, NP, partners with Livestrong program

Cancer & Hematology Centers of Western Michigan (CHCWM)’s Tami Groothuis, NP, recently beat cancer and is paying it forward by becoming a Livestrong coach, offering fitness classes for cancer survivors at the YMCA of Greater Grand Rapids. She spoke recently Read more »


START Midwest physician and clinical trial featured on ‘OncLive’

START Midwest’s Nehal Lakhani, MD, PhD, was recently featured on OncLive after his poster examining SL-172154 (SIRPα-Fc-CD40L) was presented at the 2021 Society for Immunotherapy of Cancer (SITC)’s Annual Meeting. The investigative agent was found to be “well tolerated with Read more »


CHC physician talks with Gilda’s Club Grand Rapids

Cancer & Hematology Centers of Western Michigan (CHC)’s Brett Brinker, MD, MS, recently spoke with Gilda’s Club Grand Rapids in honor of Blood Cancer Awareness Month. The discussion, which premiered on Facebook Live and highlighted blood cancer diagnosis, treatment and Read more »


Two Yuanbin Chen, MD, studies presented at ESMO 2021 Congress

Cancer & Hematology Centers of Western Michigan (CHC)’s Yuanbin Chen, MD, co-authored two studies recently presented at the European Society for Medical Oncology (ESMO)’s 2021 Congress. The first study was presented as an Eposter display titled, “1666TiP – Phase II Read more »


Page 1 of 8
Page: